authors Patorno, Elisabetta Schneeweiss, Sebastian Najafzadeh, Mehdi Pawar, Ajinkya Franklin, Jessica M Déruaz-Luyet, Anouk Brodovicz, Kimberly G Santiago Ortiz, Adrian J Lily G Bessette, MS Kulldorff, Martin
Keywords comparative effectiveness confounding (epidemiology) empagliflozin heart failure real‐world data study validity type 2 diabetes